Skip to main content
. Author manuscript; available in PMC: 2010 Mar 23.
Published in final edited form as: Pediatr Blood Cancer. 2008 Dec;51(6):806–811. doi: 10.1002/pbc.21732

Fig. 3.

Fig. 3

Survival distributions by surgical debulking for patients with recurrent malignant astrocytomas treated with either conventional chemotherapy (Chemo) or with myeloablative chemotherapy with autologous bone marrow rescue (ABMR). Chemo versus ABMR comparison stratified by surgical debulking: p=0.39. Chemo/Non-Bulky versus ABMR/Non-Bulky unstratified exact comparison: p=.017 [hazard ratio=9.1 (95% confidence interval 1.7–47.2)].